WALD – waldencast plc - class a ordinary share (US:NASDAQ)
Stock Stats
News
Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness
Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™
Waldencast (WALD) had its price target lowered by Telsey Advisory Group from $3.00 to $2.00. They now have a "market perform" rating on the stock.
Waldencast (WALD) had its price target lowered by Canaccord Genuity Group Inc. from $4.00 to $2.00. They now have a "buy" rating on the stock.
Waldencast Reports Q4 2025 and FY 2025 Financial Results [Yahoo! Finance]
Form 3 Waldencast plc For: Mar 18 Filed by: Brousset Michel
Form 3 Waldencast plc For: Mar 18 Filed by: Souza Cristiano
Form 3 Waldencast plc For: Mar 18 Filed by: Thompson Motta Roberto Moses
Form 3 Waldencast plc For: Mar 18 Filed by: Chatterley Aaron
Form 3 Waldencast plc For: Mar 18 Filed by: Dutra Felipe
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.